MEDICAL PROD UNDER FDA REG REQUIRED CONSIDER FOR DEPLOYMENT

File: 970107_sep96_decls14_0004.txt
Page: 0004
Total Pages: 11

Subject: MEDICAL PROD UNDER FDA REG REQUIRED CONSIDER FOR DEPLOYMENT     

Unit: OTSG        

Parent Organization: HSC         

Box  ID: BX003201

Folder Title: MEDICAL PRODUCTS UNDER FDA REGULATIONS                                                          

Document Number:     930001

Folder Seq  #:     930000










         4. Atropine Sulfate Inhalation Aerosol.

             a. NDA # 20-056, sponsored by the US Army Office of the
         Surgeon General. The NDA was approved 19 September 1990.

             b. Manufacturer - 3M Riker developed the product - the
         manufacturer under Government contract remains to be determined.

             c. Indication: Anticholinergic antidote for organophosphate
         poisoning. The indication cited in the NDA is the indication
         intended for use, if necessary, in operation Desert Shield.

             d. Operation Desert Shield Status: Requirements are being
         determined.

             e. Projected Production Availability for Operation Desert
         Shield: 5 to 11 weeks after a decision to procure.

             f. Point of contact: Lt Col Lehmann, 301-663-2051

Document 11 f:/Week-36/BX003201/MEDICAL PRODUCTS UNDER FDA REGULATIONS/medical prod under fda reg required consider for:01029715471415
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-36
Box ID = BX003201
Unit = OTSG
Parent Organization = HSC
Folder Title = MEDICAL PRODUCTS UNDER FDA REGULATIONS
Folder Seq # = 930000
Subject = MEDICAL PROD UNDER FDA REG REQUIRED CONSIDER FOR
Document Seq # = 930001
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 02-JAN-1997